According to OraSure Technologies's latest financial reports the company has $0.29 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.29 B | 161.99% |
2022-12-31 | $0.11 B | -27.57% |
2021-12-31 | $0.15 B | -26.91% |
2020-12-31 | $0.20 B | 33.94% |
2019-12-31 | $0.15 B | -0.15% |
2018-12-31 | $0.15 B | 1.63% |
2017-12-31 | $0.15 B | 29.33% |
2016-12-31 | $0.11 B | 17.57% |
2015-12-31 | $0.10 B | 3.53% |
2014-12-31 | $97.86 M | 5.02% |
2013-12-31 | $93.19 M | 6.03% |
2012-12-31 | $87.88 M | 268.07% |
2011-12-31 | $23.87 M | -68.47% |
2010-12-31 | $75.73 M | -4.94% |
2009-12-31 | $79.67 M | -3.46% |
2008-12-31 | $82.52 M | -13.65% |
2007-12-31 | $95.56 M | 5.02% |
2006-12-31 | $91 M | 17.24% |
2005-12-31 | $77.61 M | 16.33% |
2004-12-31 | $66.72 M | 4.22% |
2003-12-31 | $64.02 M | 329.45% |
2002-12-31 | $14.9 M | -1.86% |
2001-12-31 | $15.19 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | $0.68 B | 136.22% | ๐บ๐ธ USA |
Cooper Companies COO | $0.13 B | -53.44% | ๐บ๐ธ USA |
Trinity Biotech
TRIB | $6.26 M | -97.84% | ๐ฎ๐ช Ireland |
QuidelOrtho QDEL | $0.16 B | -42.39% | ๐บ๐ธ USA |
Chembio Diagnostics CEMI | $18.17 M | -93.74% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $1.60 B | 453.41% | ๐บ๐ธ USA |